Improving CHA(2)DS(2)-VASc stratification of non-fatal stroke and mortality risk using the Intermountain Mortality Risk Score among patients with atrial fibrillation

BACKGROUND: Oral anticoagulation (OAC) therapy guidelines recommend using CHA(2)DS(2)-VASc to determine OAC need in atrial fibrillation (AF). A usable tool, CHA(2)DS(2)-VASc is challenged by its predictive ability. Applying components of the complete blood count and basic metabolic profile, the Inte...

Descripción completa

Detalles Bibliográficos
Autores principales: Graves, Kevin G, May, Heidi T, Knowlton, Kirk U, Muhlestein, Joseph B, Jacobs, Victoria, Lappé, Donald L, Anderson, Jeffrey L, Horne, Benjamin D, Bunch, Thomas Jared
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Arrhythmias and Sudden Death
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6269639/
https://www.ncbi.nlm.nih.gov/pubmed/30564375
http://dx.doi.org/10.1136/openhrt-2018-000907

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6269639/
https://www.ncbi.nlm.nih.gov/pubmed/30564375
http://dx.doi.org/10.1136/openhrt-2018-000907

Ejemplares similares